Predictors of fetal death, neonatal survival and neurological outcomes in severe twin‐twin transfusion syndrome treated by laser ablation of placental vessels
Prenatal Diagnosis · 2024
DOI: 10.1002/pd.6523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2024. Verfasst von Cleisson Fábio Andrioli Peralta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fetal Medicine Unit, Heart Hospital (HCor), São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Fetofetal Transfusion, Perinatal Death, Laser Therapy, Polyhydramnios. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Brazilian Ministry of Health through the Programa de Desenvolvimento Institucional do Sistema Único de Saúde.
Abstract (Originalsprache)
Objectives
To identify predictors of outcomes in severe twin oligo‐polyhydramnios sequence (TOPS) with or without twin anemia‐polycythemia sequence (TAPS) and/or selective fetal growth restriction (SFGR) treated by laser ablation of placental vessels (LAPV).
Methods
Analysis of cases treated from 2011 to 2022. Variables evaluated Prenatal predictors: stages of TOPS, presence of TAPS and/or SFGR; pre‐LAPV fetal ultrasound parameters; peri‐LAPV variables. Perinatal predictors: GA at birth; birthweight; Apgar scores; transfontanellar ultrasonography (TFUS). Outcome variables: fetal death, neonatal survival, infant's neurodevelopment. Binary logistic regression analyses were performed to detect predictors of outcomes.
Results
265 cases were included. Predictors of post‐LAPV donor fetus' death were delta EFW ( p :0.045) and absent/reverse end‐diastolic flow in the umbilical artery (AREDF‐UA) ( p < 0.001). The predictor of post‐LAPV recipient fetus' death was hydrops ( p :0.009). Predictors of neonatal survival were GA at birth and Apgar scores. Predictors of infant's neurodevelopment were TFUS and pre‐LAPV middle cerebral artery Doppler (MCAD) for the donor twin; and pre‐LAPV ductus venosus' flow and MCAD for the recipient twin.
Conclusions
Prediction of fetal death, neonatal survival and infant's neurodevelopment is possible in cases of TOPS associated or not with SFGR and/or TAPS that were treated by LAPV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Fetal Medicine Unit, Heart Hospital (HCor), São Paulo, São Paulo, Brazil.
- Fetal Medicine and Surgery Center (Gestar), São Paulo, São Paulo, Brazil.
- Research Institute (HCor), São Paulo, São Paulo, Brazil.
ORCID-Profile: Cleisson Fábio Andrioli Peralta
Förderung
- Brazilian Ministry of Health through the Programa de Desenvolvimento Institucional do Sistema Único de Saúde
Zitieren
APA
Andrioli Peralta, C. F., Jorge Rodrigues da Costa, K., Peneluppi Horak, A. C., Pinheiro do Carmo Gomes, S., Sousa Santos, E., Galvão Barbante, L., & Hideo Nakagawa Santos, R. (2024). Predictors of fetal death, neonatal survival and neurological outcomes in severe twin‐twin transfusion syndrome treated by laser ablation of placental vessels. Prenatal Diagnosis. https://doi.org/10.1002/pd.6523
Vancouver
Andrioli Peralta CF, Jorge Rodrigues da Costa K, Peneluppi Horak AC, Pinheiro do Carmo Gomes S, Sousa Santos E, Galvão Barbante L, et al. Predictors of fetal death, neonatal survival and neurological outcomes in severe twin‐twin transfusion syndrome treated by laser ablation of placental vessels. Prenatal Diagnosis. 2024. doi:10.1002/pd.6523
BibTeX
@article{AndrioliPeralta2024,
author = {Andrioli Peralta, Cleisson Fábio and Jorge Rodrigues da Costa, Karina and Peneluppi Horak, Ana Clara and Pinheiro do Carmo Gomes, Samara and Sousa Santos, Elton and Galvão Barbante, Letícia and Hideo Nakagawa Santos, Renato},
title = {Predictors of fetal death, neonatal survival and neurological outcomes in severe twin‐twin transfusion syndrome treated by laser ablation of placental vessels},
journal = {Prenatal Diagnosis},
year = {2024},
doi = {10.1002/pd.6523}
}
EUVIMED